Barbara Konkle
Hematology · Seattle, WANPI 1972545796
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (41.0%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Pfizer at 33.3% of the total. Among hematology clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 159 payments — averaging $1571.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$83K
- Takeda Pharmaceuticals U.S.A., Inc.$49K
- Biomarin Pharmaceutical Inc.$41K
- Spark Therapeutics, Inc.$18K
- Bioverativ Therapeutics Inc.$14K
- Regeneron$10K
- plus $34K from 9 others
Across 336 payments — averaging $3968.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$444K
- Takeda Pharmaceuticals U.S.A., Inc.$360K
- Genentech, Inc.$150K
- Bioverativ Therapeutics Inc.$104K
- Sanofi US Services Inc.$103K
- CSL Behring$70K
- plus $102K from 4 others
What the payments were for
- Consulting fees$102,34241%
- Speaking & faculty fees$70,65028%
- Travel & lodging$75,02430%
- Food & beverage$1,7941%
- Education$130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer(2 entities) | 44 | $83,193 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $49,277 |
| Biomarin Pharmaceutical Inc. | 38 | $40,688 |
| Spark Therapeutics, Inc. | 6 | $17,728 |
| Bioverativ Therapeutics Inc. | 11 | $14,387 |
| Regeneron | 8 | $10,286 |
| Sanofi US Services Inc. | 2 | $9,536 |
| Sanofi | 15 | $8,408 |
| Octapharma USA, Inc. | 16 | $8,255 |
| Novo Nordisk Health Care AG | 1 | $2,380 |
| Genentech, Inc. | 3 | $1,998 |
| Arrow International, Inc. | 2 | $1,350 |
| F. Hoffmann-la Roche AG | 3 | $1,163 |
| Biotest AG | 1 | $1,049 |
| CSL Behring | 1 | $125 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$249,822 in reported general payments places this provider in the 95th percentile of 43 hematology providers in Washington.
Other hematology in Seattle
- Terry GernsheimerSeattle$148K
- Sandhya PanchSeattle$140K
- Roland WalterSeattle$92K
- Cecilia YeungSeattle$42K
- Kleber Yotsumoto FertrinSeattle$29K
- Jordan GauthierSeattle$17K
- David NgSeattle$9K
- Jose LopezSeattle$8K
- Geoffrey HillSeattle$8K
- Arthur ThompsonSeattle$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.